Binding Database

BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Data

Article Title

Organization

New 2-substituted 1,2,3,4-tetrahydrobenzofuro[3,2-c]pyridine having highly active and potent central alpha 2-antagonistic activity as potential antidepressants.

Janssen Research Foundation

Is there a case for P-450 inhibitors in cancer treatment?

Janssen Research Foundation

Novel triazole based inhibitors of Ras farnesyl transferase.

Janssen Research Foundation

Novel beta-(imidazol-4-yl)-beta-amino acids: solid-phase synthesis and study of their inhibitory activity against geranylgeranyl protein transferase type I.

Janssen Research Foundation

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

Array Biopharma

Oxazoline and isoxazoline derivatives as CRAC modulators

Lupin

Inhibitors of the renal outer medullary potassium channel

Merck Sharp & Dohme

Biarylether amide quinolines as liver X receptor agonists.

Wyeth Research

Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.

Human Biomolecular Research Institute

N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation.

Bristol-Myers Squibb

Novel tricyclic inhibitors of IkappaB kinase.

Bristol-Myers Squibb